Not recruiting
Hormone-refractory prostate cancer
Not recruitingStudy Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer
Registered drugNo placebo
Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer
Registered drugNo placebo
- Disease:Hormone-refractory prostate cancer
- Substances:AbirateroneBMS-986365+4
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Abiraterone
- Sponsor:Celgene Corp.



